Companies / Plus Therapeutics, Inc. / Activity
Activity — Plus Therapeutics, Inc.
33 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Sims Andrew John Hugh MacIntyre Executive | Exercise | Common Stock | $0 | +29K +20.12% | 173,913 2.53% of shares | low |
| Apr 1, 2026 | Sims Andrew John Hugh MacIntyre Executive | Exercise | Common Stock | $0 | +38K +36.00% | 144,784 2.10% of shares | low |
| Apr 1, 2026 | Hedrick Marc H CEO | Exercise | Common Stock | $0 | -202K -22.34% | 701,100 10.19% of shares | low |
| Apr 1, 2026 | Hedrick Marc H CEO | Exercise | Common Stock | $0 | +160K +46.99% | 499,468 7.26% of shares | low |
| Jan 1, 2026 | Sims Andrew John Hugh MacIntyre Executive | Exercise | Common Stock | $0 | +38K +56.24% | 106,461 1.55% of shares | low |
| Jan 1, 2026 | Hedrick Marc H CEO | Exercise | Common Stock | $0 | +160K +88.66% | 339,787 4.94% of shares | low |
| May 14, 2026 | van Es-Johansson An Director | Grant | Stock Option (Right to Buy) | — | +4K | 3,686 0.05% of shares | low |
| May 14, 2026 | van Es-Johansson An Director | Grant | Restricted Stock Units | — | +4K | 3,686 0.05% of shares | low |
| May 14, 2026 | Hawkins Richard J Director | Grant | Stock Option (Right to Buy) | — | +4K | 3,686 0.05% of shares | low |
| May 14, 2026 | Hawkins Richard J Director | Grant | Restricted Stock Units | — | +4K | 3,686 0.05% of shares | low |
| May 14, 2026 | Guse Kyle Director | Grant | Stock Option (Right to Buy) | — | +4K | 3,686 0.05% of shares | low |
| May 14, 2026 | Guse Kyle Director | Grant | Restricted Stock Units | — | +4K | 3,686 0.05% of shares | low |
| May 14, 2026 | Clowes Howard Director | Grant | Stock Option (Right to Buy) | — | +4K | 3,686 0.05% of shares | low |
| May 14, 2026 | Clowes Howard Director | Grant | Restricted Stock Units | — | +4K | 3,686 0.05% of shares | low |
| May 14, 2026 | Andrews Ronald Asbury Director | Grant | Stock Option (Right to Buy) | — | +2K | 1,600 0.02% of shares | low |
| May 14, 2026 | Andrews Ronald Asbury Director | Grant | Stock Option (Right to Buy) | — | +4K | 3,686 0.05% of shares | low |
| May 14, 2026 | Andrews Ronald Asbury Director | Grant | Restricted Stock Units | — | +4K | 3,686 0.05% of shares | low |
| May 14, 2026 | Sims Andrew John Hugh MacIntyre Executive | Grant | Stock Option (Right to Buy) | — | +3K | 3,443 0.05% of shares | low |
| May 14, 2026 | Sims Andrew John Hugh MacIntyre Executive | Grant | Restricted Stock Units | — | +3K +12.94% | 30,055 0.44% of shares | low |
| May 14, 2026 | Hedrick Marc H CEO | Grant | Stock Option (Right to Buy) | — | +24K | 23,834 0.35% of shares | low |
| May 14, 2026 | Hedrick Marc H CEO | Grant | Restricted Stock Units | — | +24K +16.30% | 170,037 2.47% of shares | low |
| Apr 20, 2026 | Daniels Eric Joseph Executive | Grant | Stock Option (Right to Buy) | — | +20K | 20,000 0.29% of shares | low |
| Apr 20, 2026 | Daniels Eric Joseph Executive | Grant | Restricted Stock Units | — | +20K | 20,000 0.29% of shares | low |
| Apr 1, 2026 | Sims Andrew John Hugh MacIntyre Executive | Exercise | Restricted Stock Units | — | -29K -4.19% | 665,322 9.67% of shares | low |
| Apr 1, 2026 | Sims Andrew John Hugh MacIntyre Executive | Exercise | Restricted Stock Units | — | -38K -5.23% | 694,451 10.09% of shares | low |
| Apr 1, 2026 | Hedrick Marc H CEO | Exercise | Restricted Stock Units | — | -202K -5.23% | 3,655,075 53.10% of shares | low |
| Apr 1, 2026 | Hedrick Marc H CEO | Exercise | Restricted Stock Units | — | -160K -3.98% | 3,856,707 56.03% of shares | low |
| Feb 25, 2026 | Sims Andrew John Hugh MacIntyre Executive | Grant | Stock Option (Right to Buy) | — | +350K | 349,541 5.08% of shares | low |
| Feb 25, 2026 | Sims Andrew John Hugh MacIntyre Executive | Grant | Restricted Stock Units | — | +350K +91.21% | 732,774 10.65% of shares | low |
| Jan 1, 2026 | Sims Andrew John Hugh MacIntyre Executive | Exercise | Restricted Stock Units | — | -38K -9.09% | 383,232 5.57% of shares | low |
| Feb 25, 2026 | Hedrick Marc H CEO | Grant | Stock Option (Right to Buy) | — | +2.4M | 2,419,582 35.15% of shares | low |
| Feb 25, 2026 | Hedrick Marc H CEO | Grant | Restricted Stock Units | — | +2.4M +151.53% | 4,016,388 58.35% of shares | low |
| Jan 1, 2026 | Hedrick Marc H CEO | Exercise | Restricted Stock Units | — | -160K -9.09% | 1,596,806 23.20% of shares | low |